REFERENCES
(1) Bethony, J. et al. “Soil-transmitted helminth infections:
ascariasis, trichuriasis, and hookworm.” Lancet 367 (2006): 1521–1532
(2) DeSilva, N.R. et al. “Soil-transmitted helminth infections:
updating the global picture.” Trends in Parasitology 19 (2003): 547-551.
(3) Hotez, PJ et al. “New technologies for the control of human
hookworm infection.” TRENDS in Parasitology 22.7 (2006): 327-331.
(4) John, David T and William A. Petri Jr. Markell and Voge’s Medical
Parasitology, Ninth Edition. St. Louis: Saunders Elsevier, 2006.
(5) “Parasites and Health: Hookworm” Centers for Disease Control and Prevention. 12 May 2007 <http://www.dpd.cdc.gov/dpdx/HTML/ Hookworm.htm>.
(6) Hotez, PJ et al. “Current Concepts: Hookworm Infection.”
The New England Journal of Medicine 351.8 (2004): 799-807.
(7) “Hookworm Infection: Parasitic Infections.” Merck Manual Home
Edition. 22 May 2007 <http://www.merck.com/mmhe/sec17/ ch196/ch196g.html>.
(8) Devaney E. "End of the Line for Hookworm? An Update on Vaccine Development." PLOS Medicine 2.10 (2005): 948-950. 1 May 2007 <http://www.plosmedicine.com>.
(9) Loukas A et al. "Hookworm Vaccines: Past, Present, and Future." The Lancet Infectious Disease 6 (2006): 733-741.
(10) Miller TA. “Vaccination against the canine hookworm diseases.” Advanced Parasitology 9 (1971): 153-83.
(11) Miller TA. “Industrial development and field use of the canine hookworm vaccine.” Advanced Parasitology 16(1978): 333-42.
(12) “The Human Hookworm Vaccine Initiative.” Albert B. Sabin Vaccine Institute. 2007. May 2007. <http://www.sabin.org/ programs/hhvi/index.html>.
(13) Hotez P, Brown A, Brooker S, Diemert D, Stoever K, Whitham M. Global Access Roadmap for the Human Hookworm Vaccine [Confidential Report]. Washington, D.C.: Human Hookworm Vaccine Initiative, Albert B. Sabin Vaccine Institute, 2006.
(14) Fujiwara RT et al. “Immunogenicity of the Hookworm Na-ASP-2 Vaccine Candidate: Characterization of Humoral and Cellular Responses after Vaccination in the Sprague Dawley Rats.” Human Vaccines 1.3 (2005): 123-8.
(15) Bethony JM et al.“Antibodies against a secreted protein from hookworm larvae reduce the intensity of infection in human and vaccinated laboratory animals.” The FASEB Journal 19 (2005): 1793-45.
(16) Hotez, Peter. Telephone Interview. 2 May 2007.
(17) “Instituto Butantan.” 2006. State secretary of Health of São Paulo, Brazil. 17 May 2007 <http://www.butantan.gov.br/>.
(18) Loukas A et al. "Vaccination with Recombinant Aspartic Hemoglobinase Reduces Parasite Load and Blood Loss After Hookworm Infection in Dogs." PLOS Medicine 2.10 (2005): 1008-1017. 10 May 2007 <http://www.plosmedicine.com>.
(19) Loukas A and P Procriv. “Immune Responses in Hookworm Infections.” Clinical Microbiology Reviews 4.14 (2001): 689-703.
(20) Prabhu C. “Omam’s immunization programme—polio vaccine trials to showcase use of Jet Injector: Workshop highlights potential for needle-free tech.” Bioject. 2002. 19 May 2007 <http://www.bioject.com/pdf/Oman%20article.pdf>.
(21) American Academy of Pediatrics Committee on Infectious
Diseases. "Poliomyelitis prevention: recommendations for use of
inactivated poliovirus vaccine and live oral poliovirus vaccine.” Pediatrics 99.2 (1997): 300-5.
(22) “Polio Vaccines.” Global Polio Eradication Initiative. World Health Organization, Rotary International, Centers for Disease Control and Prevention, and UNICEF. 18 May 2007
<http://www.polioeradication.org/vaccines.asp>.